Advertisement
Skip to Content

Quest Diagnostics Inc DGX Stock Quote

| Rating as of

NYSE: DGX

Last close prices updated as of Jan 27, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 145.63
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Mid Value
  • Day Range 145.21  –  147.33
  • Year Range 120.40  –  158.34
  • Market Cap 16.5854 Bil
  • Volume / Avg 1.0 Mil /  1.1 Mil
  • Price / Sales 3.52
  • Price / Book 2.66
  • Forward Div Yield 1.82%
  • Trailing Div Yield 1.81%

Morningstar‘s Stock Analysis DGX

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

With COVID-19 Headwinds Gathering, We've Modestly Lowered Our Fair Value Estimate for Quest

Debbie S. Wang Senior Equity Analyst

Business Strategy and Outlook

| Debbie Wang |

Quest Diagnostics has positioned itself as the leading provider of independent diagnostic testing in the U.S. by building out a network of roughly 2,300 patient service centers across the country. We think Quest's size and cost advantage allows it to benefit from several secular trends, including the proliferation of diagnostic tests and greater clinical reliance on personalized therapies. Additionally, we expect that through the intermediate term, Medicare-related pricing pressure should ease as regulators tinker with the method for setting lab test reimbursement rates.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics DGX

Company Profile DGX

Business Description

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Contact
500 Plaza Drive
Secaucus, NJ, 07094
Industry Diagnostics & Research
Employees 49,000

Related Articles DGX

FAQs for Quest Diagnostics Inc Stock

Yes. DGX has a forward dividend yield of 1.82%. See DGX’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

DGX’s market cap is 16.59 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

DGX’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

DGX’s price/sales is 3.52.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

DGX’s price/forward earnings is 16.81.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

DGX’s price/book is 2.66.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See DGX’s valuation ratios compared to the Market Index.

DGX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare DGX’s historical performance against its industry peers and the overall market.